We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Groupe Crit | EU:CEN | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.20 | -0.27% | 74.60 | 74.60 | 75.40 | 75.00 | 74.60 | 74.80 | 356 | 16:40:00 |
Hot Features
Premium
RNS Number:4413U
CeNeS Pharmaceuticals PLC
20 January 2004
CeNeS Pharmaceuticals plc
Additional Listing
Application has been made for 1,285,888 new ordinary shares to be admitted to
trading on the Alternative Investment Market of the London Stock Exchange
pursuant to the exercise of 203,075 share options at 4.9 pence each and
1,082,813 share options for #1 in aggregate. The new shares will rank pari
passu with the existing ordinary shares in the Company, and trading is expected
to commence on 22 January 2004.
Further information
Neil Clark - CeNeS Pharmaceuticals plc 01223 266 466
This information is provided by RNS
The company news service from the London Stock Exchange
END
LISPUURUGUPCGAU
1 Year Groupe Crit Chart |
1 Month Groupe Crit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
